Abionic Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 29

Abionic General Information

Description

Developer of a nanotechnology-based revolutionary biomedical diagnostic platform designed to improve medical diagnosis. The company's nanofluidic technology-based diagnostic platform offers rapid diagnostic tools to measure patients' allergy profiles, enabling healthcare professionals to enhance patient-centric diagnostic alternatives and aiding in diagnosing and screening diverse conditions with an immediate quantitative result.

Contact Information

Website
www.abionic.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Route de la Corniche 5
  • Epalinges
  • 1066 Lausanne
  • Switzerland
+41 021
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Nanotechnology, Digital Health, Life Sciences
Corporate Office
  • Route de la Corniche 5
  • Epalinges
  • 1066 Lausanne
  • Switzerland
+41 021

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abionic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC Completed Generating Revenue
12. Accelerator/Incubator Completed Generating Revenue
11. Later Stage VC (Series E) 12-Apr-2022 Completed Generating Revenue
10. Later Stage VC (Series C) 28-Mar-2018 Completed Generating Revenue
9. Secondary Transaction - Private Completed Generating Revenue
8. Early Stage VC (Series B) 14-Oct-2014 Completed Generating Revenue
7. Debt - General 30-Oct-2013 Completed Startup
6. Early Stage VC (Series A) 12-Apr-2012 Completed Startup
5. Accelerator/Incubator 01-Oct-2010 Completed Startup
4. Grant 01-Oct-2010 Completed Startup
To view Abionic’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Abionic Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a nanotechnology-based revolutionary biomedical diagnostic platform designed to improve medical diagnosis.
Diagnostic Equipment
Lausanne, Switzerland
30 As of 2025

Neuchatel, Switzerland
 

Menlo Park, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Abionic Competitors (25)

One of Abionic’s 25 competitors is 1Drop Diagnostics, a Venture Capital-Backed company based in Neuchatel, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
1Drop Diagnostics Venture Capital-Backed Neuchatel, Switzerland
LamdaGen Corporation Formerly VC-backed Menlo Park, CA
miDiagnostics Venture Capital-Backed Leuven, Belgium
Nuclein Venture Capital-Backed Austin, TX
Sense Biodetection Formerly VC-backed Abingdon, United Kingdom
You’re viewing 5 of 25 competitors. Get the full list »

Abionic Patents

  • 41

    Total Documents Applications and Grants

  • Total Patents Families

  • 33

    Granted

  • 8

    Pending

  • Expiring in next 12 mo

Abionic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021475717-A1 Method for the management of antibiotic administration Pending 25-Nov-2021
CA-3233713-A1 Method for the management of antibiotic administration Pending 25-Nov-2021
EP-4437346-A1 Method for the management of antibiotic administration Pending 25-Nov-2021
US-20250020663-A1 Method for the management of antibiotic administration Pending 25-Nov-2021
AU-2020475845-A1 Method for assessing the severity of sars Pending 03-Nov-2020 G01N33/6893
To view Abionic’s complete patent history, request access »

Abionic Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abionic Investors (29)

Investor Name Investor Type Holding Investor Since Participating Rounds
EFI Lake Geneva Ventures Venture Capital Minority
Kindmore Venture Capital Minority
3wVentures Venture Capital Minority
Angel (individual) Minority
Angel (individual) Minority
You’re viewing 5 of 29 investors. Get the full list »

Ready to get started?

Request a free trial

Abionic FAQs

  • When was Abionic founded?

    Abionic was founded in 2010.

  • Where is Abionic headquartered?

    Abionic is headquartered in Lausanne, Switzerland.

  • What is the size of Abionic?

    Abionic has 30 total employees.

  • What industry is Abionic in?

    Abionic’s primary industry is Diagnostic Equipment.

  • Is Abionic a private or public company?

    Abionic is a Private company.

  • What is Abionic’s current revenue?

    The current revenue for Abionic is .

  • How much funding has Abionic raised over time?

    Abionic has raised $30.1M.

  • Who are Abionic’s investors?

    EFI Lake Geneva Ventures, Kindmore, 3wVentures, , and are 5 of 29 investors who have invested in Abionic.

  • Who are Abionic’s competitors?

    1Drop Diagnostics, LamdaGen Corporation, miDiagnostics, Nuclein, and Sense Biodetection are some of the 25 competitors of Abionic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »